O-I Glass Announces Second Quarter 2025 Earnings Conference Call and Webcast GlobeNewswire July 02, 2025 PERRYSBURG, Ohio, July 02, 2025 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) has scheduled its second quarter 2025 conference call and webcast for Wednesday, July 30, 2025, at 8 a.m. EDT. The Company's news release for the second quarter […]

(NYSE:WST), NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline. SO

WST DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class Action – WST GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds

(NYSE:HAYW), NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Hayward Holdings, Inc. (“Hayward”) (NYSE: HAYW) Shareholders should email Fletcher@fmoorelaw.com; please contact only if shares acquired before October 27, 2021 The investigation concerns several alleged false and/or misleading statements

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hayward Holdings Inc. to Contact Law Firm GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Hayward Holdings, Inc. (“Hayward”) (NYSE: HAYW) Shareholders should email Fletcher@fmoorelaw.com;

INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people fromHPV-relateddiseases, cancer, and infectious diseases, today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof) and in either case,

(NYSE:BKH), RAPID CITY, S.D., July 02, 2025 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) will announce its 2025 second-quarter earnings after the market closes Wednesday, July 30, 2025, and will host a live conference call and webcast at 11 a.m. EDT on Thursday, July 31, 2025, to discuss the company's financial results. To participate

Black Hills Corp. Schedules 2025 Second-Quarter Earnings Release and Conference Call GlobeNewswire July 02, 2025 RAPID CITY, S.D., July 02, 2025 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) will announce its 2025 second-quarter earnings after the market closes Wednesday, July 30, 2025, and will host a live conference call and webcast at 11 a.m.

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the closing of its underwritten public offering of $115 million of shares of its common stock. Nektar sold 4,893,618 shares of common stock in the offering, which includes 638,298 shares sold upon exercise

EQT Corporation (NYSE: EQT) plans to issue its second quarter financial and operating results news release after market close on Tuesday, July 22, 2025, and will host a conference call to review the results and other relevant matters on Wednesday, July 23, 2025, beginning at 10:00 a.m. ET. A brief Q&A session for securities analysts